LawyersandSettlements.Com Releases Its Top 10 Pharmaceutical Topics For 2012

Share Article

Pharmaceutical drugs and devices continued to be some of the most popular legal news topics at during 2012. This year, contraceptives, anti-coagulants and a dialysis drug top the list as readers seek out information about harmful drug side effects and drug lawsuits., the premier publication for Online Legal Media, today released their list of the hottest consumer-related pharmaceutical legal news stories for its readership during the last year. Of note is that while the top drug-related topic on the legal news website in 2011 had been Tylenol--prompted by concerns over a series of Tylenol recall notices as reported by The New York Times; for 2012, the most sought out pharmaceutical topics have shifted to women's health

Third-generation contraceptives such as Yasmin /Yaz, NuvaRing and Mirena top the list this year as numerous birth control lawsuits either settled, or began the process of consolidation into multi-district litigation (MDL).

Reader interest in Yaz/Yasmin rose in response to Yasmin lawsuit settlements that were announced in April (In re Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Product Liability Litigation, 09-md-02100, U.S. District Court, Southern District of Illinois, East St. Louis). Bloomberg reported Bayer AG settled about 500 Yasmin lawsuits over claims of blood clots that had, in some cases, led to stroke or heart attack.

Along with Yaz, readers remained concerned about NuvaRing (etonogestrel/ethinyl estradiol) and blood clot risk even as a new study on non-oral hormonal contraception, published in the British Medical Journal (BMJ 2012;344:e2990), was presented at the annual meeting of the American College of Obstetricians and Gynecologists (May, 2012). The study, aimed at quantifying NuvaRing blood clot risk, indicated no significant difference in risk of venous thromboembolism when compared to oral contraceptives.

Still, NuvaRing lawsuits continue and have been consolidated into a federal MDL court in Missouri (In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri). As of September 5, 2012, according to the U.S. Panel on Multidistrict Litigation, more than 1,000 NuvaRing lawsuits have been filed.
Mirena IUD (levonorgestrel) saw an increase in reader interest after August 2012, as Bayer Healthcare Pharmaceuticals, Inc. submitted an Application for Centralized Management of Certain Cases involving Mirena. As FoxNews reported (11/11/12), the request seeks to create a multi-district litigation (MDL) for 16 pending Mirena lawsuits in NJ that allege Mirena caused uterine perforation, infection and hemorrhaging injuries.
After the top three women's health-related drugs, Pradaxa (dabigatran), an alternative to warfarin, joined the list this year making the Top 5. In November 2012, the FDA issued a Drug Safety Communication regarding Pradaxa bleeding events which in turn helped drive reader interest.

Thousands of monthly readers have followed the latest legal news and information on these topics, many of which have fallen from the radar of traditional media outlets.

"We believe these issues are of great importance to the public, mostly due to the life-changing impact they can have on an individual," said Stephen King, CEO. “Some of our most interesting stories of the year related to pharmaceuticals. Many of them have pending lawsuits or have had substantial settlements related to their life-altering side effects and it's important to get this information out to the public. While many pharmaceutical companies continue to earn significant profits, people are suffering. They may think they have no recourse but in many cases they do. By keeping these topics alive, is helping people stay up-to-date on these important topics every day."

The Top 10 Pharmaceutical Topics of 2012, along with the potential side effects readers were seeking information on, are:

1. Yasmin/YAZ (gall bladder disease, blood clots, deep vein thrombosis, pulmonary embolism)
2. NuvaRing & Mirena (blood clots, infection, perforation of the uterus)
3. Pradaxa (uncontrollable bleeding, lack of an available antidote)
4. Granuflo (elevated bicarbonate levels, risk for metabolic alkalosis)
5. SSRIs (birth defects including heart defects, spina bifida, cleft palate, club foot, PPHN)
6. Actos (bladder cancer, heart failure, kidney failure, rhabdomyolysis)
7. Diethylstilbestrol/DES (cancer)
8. Crestor / Statins (diabetes, cardiomyopathy, rhabdomyolysis)
9. Fosamax (bone fractures, esophageal cancer)
10. Propecia (sexual dysfunction, erectile dysfunction, sterility, prostate cancer) readers are looking for the latest and most comprehensive legal news available. Those seeking legal help can request assistance by completing a form which is then distributed to attorneys specializing in these cases. Over two and a half million people visit the site yearly, and hundreds of thousands of request forms have been submitted by qualified readers looking for legal guidance.

Founded in 2001, Online Legal Media owns and operates websites providing information for the general public and the legal community. With over 2.5 million annual visitors, hundreds of thousands of requests for legal help from its readership and over 80,000 pages of content across its sites, Online Legal Media offers the most comprehensive legal news coverage on the web. is an online legal news publication for people who face once-in-a-lifetime circumstances. serves as a portal for trial attorneys to network and to market their firms to other attorneys and legal professionals. provides pending and settled class action updates. offers up-to-date resources and news for those suffering from asbestos exposure and mesothelioma. Online Legal Media is based in Santa Cruz, California.

Follow Online Legal Media on Twitter @OnlineLegalNews and on Facebook at

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John Sliney. COO
Follow us on
Visit website